Cited by 526Systemic Lupus Erythematosus ResearchBlood Coagulation and Thrombosis MechanismsAcute Ischemic Stroke Management

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Ginsburg, Katherine S., Liang, Matthew H., Newcomer, Laura, Goldhaber, Samuel Z., Schur, Peter H., Hennekens, Charles H., Stampfer, Meir J.·1992·Annals of Internal Medicine

DOI 10.7326/0003-4819-117-12-997

Open this paper in CoChat — free account

Abstract

Objective To determine whether the presence of anticardiolipin antibodies is a risk factor for ischemic stroke and venous thrombosis in healthy adult men. Design A nested, case-control study in a prospective cohort. Setting A nationwide study of physicians. Participants The study sample was drawn from the Physicians' Health Study, a randomized, double-blind, placebo-controlled trial of aspirin and beta-carotene in 22,071 male physicians. At entry, 68% of the participants submitted plasma samples that were subsequently frozen at -80 degrees C. During 60.2 months of follow-up, follow-up for nonfatal outcomes was 99.7% complete and ascertainment of fatal outcomes was 100% complete. We identified men with documented ischemic stroke, deep venous thrombosis of the leg, or pulmonary embolus and for whom a plasma sample was available. A control was matched by age, smoking history, and length of follow-up to each of the 100 patients with ischemic stroke and the 90 patients with deep venous thrombosis or pulmonary embolus. Measurements Plasma samples were assessed for IgG anticardiolipin antibodies by enzyme-linked immunosorbent assay. The mean anticardiolipin antibody titers of the case patients in the two diagnostic groups (ischemic stroke; venous thrombosis or pulmonary embolus) were compared with those of the control groups, and relative risks were calculated for patients in increasing percentile categories of anticardiolipin antibodies by conditional logistic regression. Results T…

Integrity signals

Registry

Crossref · 10.7326/0003-4819-117-12-997

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
Harris, E. N., Boey, M. L., Mackworth-Young, C. G., Gharavi, A. E., Patel, B. M., Loizou, S., & Hughes, G. R. V. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91267-9 · Cited by 1,383
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
Alarcón-Segovia, D., Delezé, M., Oria, C. V., Sánchez‐Guerrero, J., Gómez-Pacheco, L., Cabiedes, J., Fernández, L. A. N., & de León, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 635
ARTERIAL THROMBOSIS, INTRAUTERINE DEATH AND "LUPUS" ANTICOAGULANT: DETECTION OF IMMUNOGLOBULIN INTERFERING WITH PROSTACYCLIN FORMATION
Carreras, L., Machin, S. J., Deman, R., DEFREYN, G., Vermylen, J., Spitz, B., & Assche, A. V. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92087-0 · Cited by 551
Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results.
Loizou, S., McCrea, J. D., Rudge, A. C., Reynolds, R., Boyle, C. C., & Harris, E. N. (1985) · PubMed Central · Cited by 549
Thrombosis, Recurrent Fetal Loss, and Thrombocytopenia
Harris, E. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360230069012 · Cited by 546
Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
The Steering Committee of the Physicians' Health Study Research Group (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180431 · Cited by 522

Show all 49 references

Research works printed but not linked: 15

Meyer O, 1987, J Rheum., 14, 502
Colaco C, 1983, Ann Rheum Dis., 42, 228
Harris E, 1985, J Clin Lab Immunol., 16, 1
Colaco C, 1985, Clin Exp Immunol., 59, 449
Harris E, 1987, Clin Exp Immunol., 68, 215
Hall S, 1984, J Rheum., 11, 846
Asherson R, 1989, Q J Med., 73, 1103
Cronin M, 1988, J Rheum., 15, 795
Klemp P, 1988, Clin Exp Immunol., 74, 254
Lavalle C, 1990, J Rheum., 17, 34
Coon W, 1976, Surg Gynecol Obstet., 143, 385
Hasselaar P, 1990, J Rheumatol., 17, 186
Loizou S, 1985, Clin Exp Immunol., 62, 738
Ruiz-Arguelles G, 1989, J Rheumatol., 16, 381
McNeil H, 1990, Clin Exp Rheumatol., 8, 525

Sorted by citations

Items 101–200 of 525

Pathophysiology of the antiphospholipid antibody syndrome
Willis, R., & Pierangeli, S. S. (2011) · Autoimmunity Highlights · doi:10.1007/s13317-011-0017-9 · Cited by 75
Neurological Aspects of Antiphospholipid Antibody Syndrome
Levine, S., & Brey, R. L. (1996) · Lupus · doi:10.1177/096120339600500503 · Cited by 75
A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study)
NAESS, I. A., CHRISTIANSEN, S. C., CANNEGIETER, S. C., ROSENDAAL, F. R., & HAMMERSTROEM, J. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01691.x · Cited by 74
Laboratory Evaluation of Hypercoagulability With Venous or Arterial Thrombosis
Cott, E. M. V., Laposata, M., & Prins, M. H. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1281-leohwv · Cited by 74
Lupus anticoagulant in children with thrombosis
Manco‐Johnson, M. J., & Nuss, R. (1995) · American Journal of Hematology · doi:10.1002/ajh.2830480407 · Cited by 73
Anticardiolipin antibodies as a risk factor for venous thromboembolism in a population‐based prospective study
Runchey, S. S., Folsom, A. R., Tsai, M. Y., Cushman, M., & McGovern, P. D. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03949.x · Cited by 72
NEUROLOGIC COMPLICATIONS OF ANTIPHOSPHOLIPID ANTIBODIES
Brey, R. L., Gharavi, A. E., & Lockshin, M. D. (1993) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00209-x · Cited by 72
The camptodactyly-arthropathy-coxa vara-pericarditis syndrome: Clinical features and genetic mapping to human chromosome 1
Bahabri, S., Suwairi, W. M., Laxer, R. M., Polinkovsky, A., Dalaan, A. A., & Warman, M. L. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199804)41:4 · Cited by 105
Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE
Wu, R., Svenungsson, E., Gunnarsson, I., Andersson, B., Lundberg, I. E., Elinder, L. S., & Frostegård, J. (1999) · Lupus · doi:10.1191/096120399678847434 · Cited by 70
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?
Barbhaiya, M., & Erkan, D. (2011) · Current Rheumatology Reports · doi:10.1007/s11926-010-0149-3 · Cited by 69
Management of Thrombosis in the Antiphospholipid Syndrome
Khamashta, M. A. (1996) · Lupus · doi:10.1177/096120339600500527 · Cited by 69
Anticardiolipin Antibodies in Normal Subjects
Schmidt, R., Auer‐Grumbach, P., Fazekas, F., Offenbacher, H., & Kapeller, P. (1995) · Stroke · doi:10.1161/01.str.26.5.749 · Cited by 67
ANTIPHOSPHOLIPID ANTIBODY SYNDROME
Lockshin, M. D. (1994) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00225-8 · Cited by 67
Prevalence and clinical significance of IgG isotype anti-β2-glycoprotein I antibodies in antiphospholipid syndrome: A comparative study w
Sanmarco, M., Soler, C., Christides, C., Raoult, D., Weiller, P. J., Gérolami, V., & Bernard, D. J. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90004-4 · Cited by 67
Antiphospholipid thrombosis syndromes
Bick, R. L. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(02)00103-x · Cited by 64
PREVALENCE AND CLINICAL SIGNIFICANCE OF ANTIPHOSPHOLIPID ANTIBODIES IN RENAL TRANSPLANT RECIPIENTS
Ducloux, D., Pellet, E., Fournier, V. R., Rebibou, J.-M., Bresson–Vautrin, C., Racadot, E., FELLMANN, D., & Chalopin, J. (1999) · Transplantation · doi:10.1097/00007890-199901150-00015 · Cited by 66
Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children
Lanthier, S., Kirkham, F. J., Mitchell, L. G., Laxer, R. M., Atenafu, E. G., Male, C., Prengler, M., Domi, T., Chan, A. K. C., Liesner, R. J., et al. (2004) · Neurology · doi:10.1212/wnl.62.2.194 · Cited by 66
Antiphospholipid Antibodies in Young Adults with Stroke
Brey, R. L. (2005) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-005-3204-6 · Cited by 64
Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder
D’Ippolito, S., Meroni, P. L., Koike, T., Veglia, M., Scambia, G., & Simone, N. D. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.004 · Cited by 64
Anticardiolipin antibodies and their associations with cerebrovascular risk factors
Tanné, D., D'Olhaberriague, L., Schultz, L. R., Salowich‐Palm, L., Sawaya, K. L., & Levine, S. R. (1999) · Neurology · doi:10.1212/wnl.52.7.1368 · Cited by 63
Association of silicone breast implants with immunologic abnormalities: a prospective study
Karlson, E. W., Hankinson, S. E., Liang, M. H., Sánchez‐Guerrero, J., Colditz, G. A., Rosenau, B. J., Speizer, F. E., & Schur, P. H. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00358-1 · Cited by 62
Self-citation
Neurologic Manifestations of the Antiphospholipid Syndrome — an Update
Rato, M. L., Bandeira, M., Romão, V. C., & de Sousa, D. A. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01124-z · Cited by 63
Antiphospholipid syndrome
Khamashta, M. A., Taraborelli, M., Sciascia, S., & Tincani, A. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.04.002 · Cited by 66
Antiphospholipid antibodies and thrombosis: strength of association
Galli, M., & Barbui, T. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200206 · Cited by 61
Cerebrovascular Events in Patients With Significant Stenosis of the Carotid Artery Are Associated With Hyperhomocysteinemia and Platelet Antigen-1 (Leu33Pro) Polymorphism
Streifler, J. Y., Rosenberg, N., Chetrit, A., Eskaraev, R., Sela, B., Dardik, R., Zivelin, A., Ravid, B., Davidson, J., Seligsohn, U., et al. (2001) · Stroke · doi:10.1161/hs1201.099650 · Cited by 60
Thrombophilic Genotypes in Subjects with Idiopathic Antiphospholipid Antibodies – Prevalence and Significance
Tommasino, C., D’Andrea, G., Iannaccone, L., Brancaccio, V., Margaglione, M., & Ames, P. R. J. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614217 · Cited by 60
The Frequency of Phospholipid Antibodies in an Unselected Stroke Population
Metz, L., Edworthy, S. M., Mydlarski, R., & Fritzler, M. J. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100033515 · Cited by 59
Anticardiolipin Antibodies and Mortality in Patients with Ischemic Stroke: A Prospective Follow-Up Study
Tanné, D., D'Olhaberriague, L., Trivedi, A. M., Salowich‐Palm, L., Schultz, L. R., & Levine, S. R. (2002) · Neuroepidemiology · doi:10.1159/000048623 · Cited by 58
DIAGNOSIS OF ANTIPHOSPHOLIPID ANTIBODIES
Petri, M. (1994) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00057-0 · Cited by 58
Evidence of absence or absence of evidence? A reanalysis of the effects of low-dose aspirin in in vitro fertilization
Ruopp, M. D., Collins, T. C., Whitcomb, B. W., & Schisterman, E. F. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.06.033 · Cited by 57
Statins for the Treatment of Antiphospholipid Syndrome?
Jajoria, P., Murthy, V. L., Papalardo, E., Romay‐Penabad, Z., Gleason, C. E., & Pierangeli, S. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04815.x · Cited by 55
Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case–control study
Martínez‐Zamora, M. Á., Peralta, S., Creus, M. T., Tàssies, D., Reverter, J. C., Espinosa, G., Cervera, R., Carmona, F., & Balasch, J. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.153817 · Cited by 54
Oxidized Low-Density Lipoprotein/β2-Glycoprotein I Complexes and Autoantibodies to oxLig-1/β2-Glycoprotein I in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Lopez, D., García-Valladares, I., Palafox‐Sánchez, C. A., Torre, I. G.-D. L., Kobayashi, K., Matsuura, E., & Lopez, L. R. (2004) · American Journal of Clinical Pathology · doi:10.1309/2aue6hd4w6tleuu5 · Cited by 55
Antiphospholipid syndrome: An evolving story
Robertson, B. J., & Greaves, M. (2006) · Blood Reviews · doi:10.1016/j.blre.2005.12.001 · Cited by 54
Antiphospholipid antibodies and the antiphospholipid syndrome
Harris, E. N., & Pierangeli, S. S. (1994) · Springer Seminars in Immunopathology · doi:10.1007/bf00197519 · Cited by 55
Antiphosphatidyl serine antibodies are independently associated with ischemic stroke
Tuhrim, S., Rand, J. H., Wu, X.-X., Horowitz, D. R., Weinberger, J., Goldman, M., & Godbold, J. (1999) · Neurology · doi:10.1212/wnl.53.7.1523 · Cited by 54
Antiphospholipid-Protein Antibodies and Ischemic Stroke
Tanné, D., Triplett, D. A., & Levine, S. R. (1998) · Stroke · doi:10.1161/01.str.29.9.1755 · Cited by 54
Thrombosis and the Antiphospholipid Syndrome
Ortel, T. L. (2005) · Hematology · doi:10.1182/asheducation-2005.1.462 · Cited by 53
Hughes Syndrome, the Antiphospholipid Syndrome: A New Chapter in Neurology
Sanna, G., Bertolaccini, M. L., & Hughes, G. R. V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1361.088 · Cited by 53
IgG Autoantibodies against β2‐Glycoprotein I Complexed with a Lipid Ligand Derived from Oxidized Low‐Density Lipoprotein are Associated with Arterial Thrombosis in Antiphospholipid Syndrome
Lopez, D., Kobayashi, K., Merrill, J. T., Matsuura, E., & Lopez, L. R. (2003) · Journal of Immunology Research · doi:10.1080/10446670310001642113 · Cited by 53
Endosomal NADPH-oxidase is critical for induction of the tissue factor gene in monocytes and endothelial cells
Prinz, N., Clemens, N., Canisius, A., & Lackner, K. J. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0421 · Cited by 55
MANAGEMENT OF THROMBOSIS IN ANTIPHOSPHOLIPID ANTIBODY SYNDROME
Petri, M. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70225-8 · Cited by 51
Factor V Leiden, Antiphospholipid Antibodies and Thrombosis in Systemic Lupus Erythematosus
Fijnheer, R., Horbach, D. A., Donders, R. C. J. M., Vilé, H. A., van Oort, E., Nieuwenhuis, H. K., Gmelig-Meyling, F. H. J., de Groot, P. G., & Derksen, R. H. W. M. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650614 · Cited by 52
Association between periodontitis and anti‐cardiolipin antibodies in Buerger disease
Chen, Y., Nagasawa, T., Wara-aswapati, N., 牛田, 由., Wang, D., Takeuchi, Y., Kobayashi, H., Umeda, M., Inoue, Y., Iwai, T., et al. (2009) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2009.01467.x · Cited by 51
Role of tissue factor in thrombosis in antiphospholipid antibody syndrome
Boles, J. C., & Mackman, N. (2010) · Lupus · doi:10.1177/0961203309360810 · Cited by 50
What is antiphospholipid syndrome?
Erkan, D., & Lockshin, M. D. (2004) · Current Rheumatology Reports · doi:10.1007/s11926-004-0024-1 · Cited by 50
Are Oxidized LDL/β2‐glycoprotein I Complexes Pathogenic Antigens in Autoimmune‐mediated Atherosclerosis?
Matsuura, E., & Lopez, L. R. (2004) · Journal of Immunology Research · doi:10.1080/10446670410001722186 · Cited by 50
Hypercoagulation Testing in Ischemic Stroke
Rahemtullah, A., & Cott, E. M. V. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-890-htiis · Cited by 50
Frequent Hemodialysis Graft Thrombosis: Association With Antiphospholipid Antibodies
Prieto, L. N., & Suki, W. N. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80383-0 · Cited by 50
The Antiphospholipid Syndrome
Rand, J. H. (2007) · Hematology · doi:10.1182/asheducation-2007.1.136 · Cited by 49
Coagulopathies and Arterial Stroke
Moster, M. L. (2003) · Journal of Neuro-Ophthalmology · doi:10.1097/00041327-200303000-00012 · Cited by 49
Antiphospholipid antibody syndrome and renal disease
Joseph, R. E., Radhakrishnan, J., & Appel, G. B. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200103000-00004 · Cited by 49
Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant
Le, D., Griffin, J. H., Greengard, J. S., Mujumdar, V. S., & Rapaport, S. (1995) · Blood · doi:10.1182/blood.v85.7.1704.bloodjournal8571704 · Cited by 49
Antiphospholipid antibodies — We are not quite there yet
Urbanus, R. T., & de Groot, P. G. (2011) · Blood Reviews · doi:10.1016/j.blre.2010.12.001 · Cited by 48
The anti-phospholipid syndrome
Devine, D. V., & Brigden, M. L. (1996) · Postgraduate Medicine · doi:10.1080/00325481.1996.11946139 · Cited by 48
Antiphospholipid antibody. Babies, blood clots, biology
Lockshin, M. D. (1997) · JAMA · doi:10.1001/jama.277.19.1549 · Cited by 47
Laboratory diagnosis and management challenges in the antiphospholipid syndrome
Bertolaccini, M. L., & Khamashta, M. A. (2006) · Lupus · doi:10.1191/0961203306lu2293rr · Cited by 47
Thrombosis and Antiphospholipid Syndrome: a Preliminary Assessment of Three Antithrombotic Treatments
Rivier, G., Herranz, M., Khamashta, M. A., & Hughes, G. R. V. (1994) · Lupus · doi:10.1177/096120339400300205 · Cited by 47
The presence of multiple prothrombotic risk factors is associated with a higher risk of thrombosis in individuals with anticardiolipin antibodies.
Hudson, M., Herr, A.-L., Rauch, J., Neville, C., Chang, E. R., Ibrahim, R., Séguin, C., Kassis, J., Busque, L., & Fortin, P. R. (2003) · PubMed · Cited by 46
Value of immunologic testing in stroke patients. A prospective multicenter study.
Montalbán, X., Río, J., Khamastha, M., Dávalos, A., Codina, M., Swana, G. T., Calcagnotto, M. E., Sumalla, J., Hengstl, S. M., & Gil, A. (1994) · Stroke · doi:10.1161/01.str.25.12.2412 · Cited by 46
Tissue factor in the antiphospholipid syndrome
Kinev, A., & Roubey, R. (2008) · Lupus · doi:10.1177/0961203308096662 · Cited by 45
Revised classification criteria for antiphospholipid syndrome and the thrombotic risk in patients with autoimmune diseases
SWADŹBA, J., IWANIEC, T., SZCZEKLIK, A., & MUSIAŁ, J. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02669.x · Cited by 44
Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study
Zuily, S., Regnault, V., Guillemin, F., Kaminsky, P., Rat, A., Lecompte, T., & Wahl, D. G. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.04.012 · Cited by 44
Management of the neurological manifestations of APS—what do the trials tell us?
Brey, R. L. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.018 · Cited by 44
The mechanical basis of impaired esophageal emptying postfundoplication
Ghosh, S. K., Kahrilas, P. J., Zaki, T. A., Pandolfino, J. E., Joehl, R. J., & Brasseur, J. G. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00235.2004 · Cited by 44
Antiphospholipid antibodies may be a new prognostic parameter in aggressive non‐Hodgkin's lymphoma
Bairey, O., Blickstein, D., Monselise, Y., Lahav, J., Stark, P., Prokocimer, M., Magen‐Nativ, H., Kirgner, I., Pazgal, I., & Shaklai, M. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2005.00620.x · Cited by 44
Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying 'Membrane Stress Syndrome' Hypothesis
Ames, P. R. J. (1994) · Lupus · doi:10.1177/096120339400300503 · Cited by 42
Antiphospholipid (Hughes) Syndrome
Khamashta, M. A., Bertolaccini, M. L., & Hughes, G. R. V. (2004) · Autoimmunity · doi:10.1080/08916930410001708706 · Cited by 44
Progressive Prothrombotic State in Women With Advancing HIV Disease
Levine, A. M., Vigen, C. L. P., Gravink, J., Mack, W. J., Watts, C. H., & Liebman, H. A. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000230320.78288.79 · Cited by 43
Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and β2-glycoprotein I (β2-GPI) in systemic lupus erythematosus
Wu, R., Svenungsson, E., Gunnarsson, I., HAEGERSTRAND-GILLIS, C., Andersson, B., Lundberg, I. E., Elinder, L. S., & Frostegård, J. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00830.x · Cited by 43
Autoimmune-mediated atherothrombosis
Matsuura, E., & Lopez, L. (2008) · Lupus · doi:10.1177/0961203308093553 · Cited by 42
Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
van Goor, M. P. J., Alblas, C. L., Leebeek, F. W. G., Koudstaal, P. J., & Dippel, D. W. J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00241.x · Cited by 42
Ocular involvement in primary antiphospholipid syndrome
Demirci, F. Y., Küçükkaya, R. D., Akarçay, K., Kır, N., Atamer, T., Demirci, H., & Öngör, E. (1998) · International Ophthalmology · doi:10.1023/a:1006305705080 · Cited by 42
Antibodies to C reactive protein
Rosenau, B. J., & Schur, P. H. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037895 · Cited by 42
Self-citation
Primary Prevention of Thrombosis in Subjects with Positive Antiphospholipid Antibodies
Khamashta, M. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0421 · Cited by 42
Lipids, cardiovascular disease and atherosclerosis in systemic lupus erythematosus
Wierzbicki, A. S. (2000) · Lupus · doi:10.1191/096120300678828235 · Cited by 42
Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study
Heinzlef, O., Abuaf, N., Cohen, A. A., & Amarenco, P. (2001) · Journal of Neurology · doi:10.1007/s004150170176 · Cited by 41
Diagnosis of antiphospholipid syndrome
Bertolaccini, M. L., Khamashta, M. A., & Hughes, G. R. V. (2005) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0017 · Cited by 40
CLASSIFICATION CRITERIA FOR ANTIPHOSPHOLIPID SYNDROME
Wilson, W. A. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70216-7 · Cited by 41
The Antiphospholipid Syndrome
Fischer, M. J., Rauch, J., & Levine, J. S. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2006.09.006 · Cited by 41
Pulmonary Manifestations of the Antiphospholipid Antibody Syndrome
Ford, H. J., & Roubey, R. A. S. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.05.005 · Cited by 39
Pregnancy and thrombophilia
Patnaik, M. M., Haddad, T. C., & Morton, C. T. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.4.753 · Cited by 40
Thrombophilia Testing After Ischemic Stroke
Omran, S. S., Hartman, A., Zakai, N. A., & Navi, B. B. (2021) · Stroke · doi:10.1161/strokeaha.120.032360 · Cited by 44
Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice
Roubey, R. (2010) · Lupus · doi:10.1177/0961203310361356 · Cited by 39
Update on antiphospholipid antibody syndrome
Lopes, M. R. U., Danowski, A., Funke, A., Rêgo, J., Levy, R. A., & ANDRADE, D. C. O. D. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.11.994 · Cited by 38
The antiphospholipid syndrome – often overlooked cause of vascular occlusions?
Svenungsson, E., & Antovič, A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13022 · Cited by 39
HUGHES (ANTIPHOSPHOLIPID) SYNDROME
Cuadrado, M. J., & Hughes, G. R. V. (2001) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70217-9 · Cited by 39
Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach
Favaloro, E. J., Silvestrini, R. A., & Mohammed, A. (1999) · Pathology · doi:10.1080/003130299105331 · Cited by 39
Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke
Kahles, T., Humpich, M. C., Steinmetz, H., Sitzer, M., & Lindhoff‐Last, E. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/keh698 · Cited by 38
Neurologic manifestations of the antiphospholipid syndrome
Tanné, D., & Hassin‐Baer, S. (2001) · Current Rheumatology Reports · doi:10.1007/s11926-001-0032-3 · Cited by 38
Systemic thrombosis in patients with antiphospholipid antibodies: lesion distribution and imaging findings.
Provenzale, J. M., Ortel, T. L., & Allen, N. B. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.2.9456930 · Cited by 38
State-of-the-Art Review: Antiphospholipid Thrombosis Syndromes
Bick, R. L. (2001) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960100700401 · Cited by 39
Abnormal IgG cardiolipin antibody titers in patients with Raynaud’s phenomenon and/or related disorders: Prevalence and clinical significance
VAYSSAIRAT, M., Abuaf, N., Baudot, N., Deschamps, A., & Gaitz, J. P. (1998) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(98)70116-1 · Cited by 38
Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence
Clark, C. A., Laskin, C. A., & Spitzer, K. A. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms020 · Cited by 37
Anti–Domain I β2-Glycoprotein I Antibodies and Activated Protein C Resistance Predict Thrombosis in Antiphospholipid Syndrome: TAC(I)T Study
Zuily, S., de Laat, B., Guillemin, F., Kelchtermans, H., Magy-Bertrand, N., Desmurs‐Clavel, H., Lambert, M., Poindron, V., de Maistre, E., Dufrost, V., et al. (2020) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaa072 · Cited by 38
Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism
Zanon, E., Prandoni, P., Vianello, F., Saggiorato, G., Carraro, G., Bagatella, P., & Girolami, A. (1999) · Thrombosis Research · doi:10.1016/s0049-3848(99)00105-x · Cited by 38
Hypercoagulable states in patients with retinal venous occlusion
El‐Asrar, A. M. A., Gader, A. G. M. A., Al-Amro, S. A., & Al-Momen, A. (1998) · Documenta Ophthalmologica · doi:10.1023/a:1001795918894 · Cited by 37
Thrombosis in systemic lupus erythematosus: risk and protection
Burgos, P. I., & Alarcón, G. S. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.137 · Cited by 34
Role of Thrombotic Vascular Risk Factors in Inflammatory Bowel Disease
Κoutroubakis, I. E. (2000) · Digestive Diseases · doi:10.1159/000051389 · Cited by 36
Recent insights into antiphospholipid antibody-mediated thrombosis
Field, S. L., Brighton, T., McNeil, H. P., & Chesterman, C. N. (1999) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.1999.0033 · Cited by 34

Authors: Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Liang, Matthew H.
Goldhaber, Samuel Z.
Hennekens, Charles H.
Stampfer, Meir J.
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 1992-12-15
Volume: 117
Issue: 12
Pages: 997-1002
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-117-12-997
OpenAlex: W1491481195
Cited by: 526
References: 49
Citations by year: 2025: 2 · 2024: 7 · 2023: 5 · 2022: 1 · 2021: 8 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 15 · 2012: 16
FWCI: 16.25
Type: journal article
Language: en
Open access: closed
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA042182, CA 42182)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60AR036308, AR-36308, AR-07530, T32AR007530)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Keywords: anticardiolipin antibodies, ischemic stroke, venous thrombosis, deep vein thrombosis, pulmonary embolism, thrombophilia, risk factors, IgG, male physicians, Physicians' Health Study, aspirin, beta-carotene, anticoagulation, stroke prevention, antithrombotic therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Brain Ischemia, Enzyme-Linked Immunosorbent Assay, Humans, Male, Middle Aged, Prospective Studies, Pulmonary Embolism, Risk Factors, Statistics as Topic, Thrombophlebitis, Case-Control Studies, Antibodies, Anticardiolipin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks